Thirty-seven myasthenic patients were treated with therapeutic plasma exchange (TPE) on different performance schedules using either random or single donor plasma. The two schedules had the same effects in terms of efficacy but single donor replacement gave significantly less side effects in the short and long term. A two exchange procedure on alternate days associated with immunosuppression seems to be an optimal schedule for the treatment of myasthenic patients. A single donor two-exchange on alternate days procedure appears to be safe, useful and can be repeated in patients who need frequent TPE.
ChopekM., McCullonghJ.Protein and biochemical changes during plasma exchange. In therapeutic hemapheresis. A technical workshop, BerkmanE.M., UmlasJ. eds, Washington DC, 1980.
PinchingA.J., PetersD.K., Newson-DavisJ.Remission of myasthenia gravis following plasma-exchange. Lancet, 1976; 2, 1373–6.
5.
DauP.C., LindstromJ.M., CasselS.K., DenysE.H., SherE.E., SpitlerL.E.Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. New Engl J Med1977; 297, 1134–40.
6.
BehanP.O., ShakirR.A., SimpsonJ.A., BurnettA.K., AllanT.L., HaaseG.Plasma-Exchange combined with immuno-suppresive therapy in myasthenia gravis. The Lancet1979; 2, 438–40.
7.
LisakR.P.Plasmapheresis in myasthenia gravis: three years experience. In: SchotlandD.L. ed. Disorders of the motor unit.New York: John Wiley and Sons Inc, 1982; 295–7.
8.
Newsom-DavisJ., VincentA., WilsonS.G., WardC.D.Long term effect of repeated plasma-exchange in myasthenia gravis. The Lancet1979; 2, 464–8.
9.
Newsom-DavisJ., PinchingA.J., VincentA., WilsonS.G.Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma-exchange. Neurology1978; 28, 266–72.
